fashion -WSS

fashion

author：hotspot 2025-09-27 21:28:00 - browse：6454

LONDON — AstraZeneca said on Monday that a new lung cancer treatment outperformed standard-of-care chemotherapy in a trial, but investors found the results less impressive than anticipated, sending company shares down in early trading.

Based on an interim analysis of a Phase 3 trial, the company said that the drug, datopotamab deruxtecan, led to improvement in progression-free survival in patients non-small cell lung cancer, a primary endpoint of the study. There was also a positive early trend on overall survival, with Susan Galbraith, AstraZeneca’s oncology leader, describing the results as “compelling evidence for the potential role” that the drug could play for patients.

But investors had been hoping for a clearer signal of benefit. Analysts noted that despite the success in progression-free survival, it was not described as a “clinically meaningful” improvement, which, as J.P. Morgan analysts wrote, “we believe the market would have liked to have seen.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Democratic lawmaker calls for 'well

focus

WSS

Biden will tout long

Arena BioWorks launches in Cambridge to speed drug discovery

American taxpayers paid $1.8 trillion in health care costs in 2022

In medicine, common shorthands can shortchange care

Ascension's ugly legal battle over care for poor patients in Texas

Stories you might have missed in 2023: health, science, medicine

focus

fashion

leisure time

Wildfire smoke exposes gaps in outdoor worker protections

Fauci's latest grilling in Congress: 9 hours, behind closed doors

Tori Bowie and the unacceptable rates of Black maternal death

Thousands in Haiti march to demand safety from violent gangs as killings and kidnappings soar

Medicare proposal to cover medical devices draws a mixed reaction

Study suggests new cause of Down syndrome: cells linked to aging

Medical records are filled with copy

Boeing's 1st astronaut flight bumped into next year, more repairs needed

BioMarin wins approval for gene therapy to treat hemophilia A

South Korea begins evacuating thousands of Scouts from coastal campsite as tropical storm nears

explore

Gene therapy denied for Afghan refugee whose father aided U.S.

3 dead in firefighting helicopter crash in California after midair collision with 2nd helicopter

Life science postdocs should get big pay hike, NIH panel says

DeSantis and Newsom agree to Sean Hannity debate, then disagree on the rules

Illinois to ban advertising for guns allegedly marketed to kids and militants

In shift, Texas to cover initial consult for Afghan baby's gene therapy

entertainment

entertainment

focus

hotspot